Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.
Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. Chivese T, et al. Among authors: cyprian f. Pathog Glob Health. 2022 Jul;116(5):269-281. doi: 10.1080/20477724.2022.2029301. Epub 2022 Jan 31. Pathog Glob Health. 2022. PMID: 35099367 Free PMC article.
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.
Bansal D, Abdulmajeed J, Al-Shamali MHMA, Albayat SSA, Himatt SM, Cyprian FS, Chivese T, Mundodan JMA, Khogali HS, Baaboura R, Kaleeckal AH, Kandy MC, Latif AN, Al-Kuwari MG, Al-Romaihi HE, Al Khal A, Bertollini R, Al-Thani MH, Farag E, Doi SAR. Bansal D, et al. Vaccines (Basel). 2022 Jun 28;10(7):1036. doi: 10.3390/vaccines10071036. Vaccines (Basel). 2022. PMID: 35891199 Free PMC article.
Identification of Prognostic Metabolomic Biomarkers at the Interface of Mortality and Morbidity in Pre-Existing TB Cases Infected With SARS-CoV-2.
Diboun I, Cyprian FS, Anwardeen NR, Yassine HM, Elrayess MA, Rahmoon SM, Sayed SK, Schuchardt S, Khatib M, Bansal D, Farag EABA, Emara MM, Abdallah AM. Diboun I, et al. Among authors: cyprian fs. Front Cell Infect Microbiol. 2022 Jul 22;12:929689. doi: 10.3389/fcimb.2022.929689. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35937683 Free PMC article.
Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.
Bansal D, Atia H, Al Badr M, Nour M, Abdulmajeed J, Hasan A, Al-Hajri N, Ahmed L, Ibrahim R, Zamel R, Mohamed A, Pattalaparambil H, Daraan F, Chaudhry A, Oraby S, El-Saleh S, El-Shafie SS, Al-Farsi AF, Paul J, Ismail A, Al-Romaihi HE, Al-Thani MH, Doi SAR, Zughaier SM, Cyprian F, Farag E, Farooqui HH. Bansal D, et al. Among authors: cyprian f. Vaccines (Basel). 2023 Feb 21;11(3):496. doi: 10.3390/vaccines11030496. Vaccines (Basel). 2023. PMID: 36992080 Free PMC article.
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G. Cyprian FS, et al. Front Immunol. 2021 Dec 13;12:707159. doi: 10.3389/fimmu.2021.707159. eCollection 2021. Front Immunol. 2021. PMID: 34966381 Free PMC article.
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma MM, Kuni RAT, Abdelmajid A, Abdelhafez I, Arif R, Mulhim M, Abukhattab M, Dar SR, Moustafa AA, Elkord E, Al Khal AL, Elzouki AN, Cyprian F. Parray A, et al. Among authors: cyprian f. Vaccines (Basel). 2021 Sep 23;9(10):1056. doi: 10.3390/vaccines9101056. Vaccines (Basel). 2021. PMID: 34696164 Free PMC article.
39 results